Tumors formed by GH4C1 cell lines carrying different genotypes exhibited varying levels of mTOR pathway activation and growth rates.EVE reduced tumor volume, lowered GH levels, and inhibited p-S6. This evidence concerns the gene MTOR and neoplasm.